| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.CIR.102.8.915 |
| P698 | PubMed publication ID | 10952962 |
| P50 | author | Ana Martín-Villalba | Q15451540 |
| Klaus-Michael Debatin | Q18022197 | ||
| Irmela Jeremias | Q63980322 | ||
| P2093 | author name string | Schenkel J | |
| Boekstegers P | |||
| Habazettl H | |||
| Kupatt C | |||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cell death | Q2383867 |
| myocardial ischemia | Q6947906 | ||
| P304 | page(s) | 915-920 | |
| P577 | publication date | 2000-08-01 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Involvement of CD95/Apo1/Fas in cell death after myocardial ischemia | |
| P478 | volume | 102 |
| Q38637311 | Abnormalities in Alternative Splicing of Apoptotic Genes and Cardiovascular Diseases |
| Q34997854 | Activation of Mst1 causes dilated cardiomyopathy by stimulating apoptosis without compensatory ventricular myocyte hypertrophy |
| Q41718620 | Adipose-derived stem cell-released osteoprotegerin protects cardiomyocytes from reactive oxygen species-induced cell death |
| Q33623568 | Apoptosis in ischemic heart disease |
| Q22242031 | Apoptosis in myocardial ischaemia and infarction |
| Q46149874 | Balanced expression of mitochondrial apoptosis regulatory proteins correlates with long-term survival of cardiac allografts |
| Q39656970 | CD95 is a key mediator of invasion and accelerated outgrowth of mouse colorectal liver metastases following radiofrequency ablation |
| Q40459939 | CD95/Apo-1/Fas: independent cell death induced by doxorubicin in normal cultured cardiomyocytes. |
| Q51828037 | Cardiomyocyte death in patients with end-stage heart failure before and after support with a left ventricular assist device: low incidence of apoptosis despite ubiquitous mediators. |
| Q38072123 | Caspase-3 as a therapeutic target for heart failure. |
| Q36903477 | Caspases in myocardial infarction. |
| Q42571029 | Cell death, dysglycemia and myocardial infarction |
| Q36768874 | Cell suicide and caspases |
| Q35844620 | Cold ischemic injury of transplanted kidneys: new insights from experimental studies |
| Q34401648 | Critical role of interferon regulatory factor-1 in murine liver transplant ischemia reperfusion injury |
| Q36070078 | Death begets failure in the heart |
| Q26865568 | Death receptor-ligand systems in cancer, cell death, and inflammation |
| Q36275682 | Don't lose heart--therapeutic value of apoptosis prevention in the treatment of cardiovascular disease. |
| Q28345320 | Dynamic process of apoptosis in adult rat cardiomyocytes analyzed using 48-hour videomicroscopy and electron microscopy: beating and rate are associated with the apoptotic process |
| Q73400458 | Effect of maternal chronic hypoxic exposure during gestation on apoptosis in fetal rat heart |
| Q37661552 | Elevated plasma IL-37, IL-18, and IL-18BP concentrations in patients with acute coronary syndrome. |
| Q40671712 | Endothelial cell overexpression of fas ligand attenuates ischemia-reperfusion injury in the heart |
| Q88483632 | Exosomal miR-21a-5p mediates cardioprotection by mesenchymal stem cells |
| Q54456353 | Extracellular matrix protein CCN1 regulates cardiomyocyte apoptosis in mice with stress-induced cardiac injury. |
| Q35949342 | FAK regulates cardiomyocyte survival following ischemia/reperfusion |
| Q33837045 | FLIP protects against hypoxia/reoxygenation-induced endothelial cell apoptosis by inhibiting Bax activation |
| Q35820717 | Fas (CD95) induces macrophage proinflammatory chemokine production via a MyD88-dependent, caspase-independent pathway |
| Q46592230 | Fas-independent mitochondrial damage triggers cardiomyocyte death after ischemia-reperfusion |
| Q47377679 | Gene transfer of the pancaspase inhibitor P35 reduces myocardial infarct size and improves cardiac function |
| Q42918384 | Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT. |
| Q35753015 | Hsp70 may protect cardiomyocytes from stress-induced injury by inhibiting Fas-mediated apoptosis |
| Q34277445 | Hydrogen sulfide attenuates cardiac dysfunction in a rat model of heart failure: a mechanism through cardiac mitochondrial protection |
| Q92581881 | Hydroxysafflor Yellow A mitigated myocardial ischemia/reperfusion injury by inhibiting the activation of the JAK2/STAT1 pathway |
| Q28564545 | Hypoxia predisposes neonatal rat ventricular myocytes to apoptosis induced by activation of the Fas (CD95/Apo-1) receptor: Fas activation and apoptosis in hypoxic myocytes |
| Q33807897 | Immunological and histopathological changes in the atrial tissue during and after cardiopulmonary bypass |
| Q44026937 | Importance of FADD signaling in serum deprivation- and hypoxia-induced cardiomyocyte apoptosis |
| Q35580575 | Increased plasma concentrations of interleukin-18 in acute coronary syndromes. |
| Q36807253 | Inhibition of Fas-Fas ligand interaction attenuates microvascular hyperpermeability following hemorrhagic shock |
| Q43235366 | Inhibition of cytochrome c release by 10-N-nonyl acridine orange, a cardiolipin-specific dye, during myocardial ischemia-reperfusion in the rat. |
| Q36014531 | Inhibition of ischemic cardiomyocyte apoptosis through targeted ablation of Bnip3 restrains postinfarction remodeling in mice |
| Q39109413 | Ischemia/Reperfusion |
| Q35087829 | Ischemic preconditioning: fact or fantasy? |
| Q35697472 | Mechanisms of apoptosis in the heart |
| Q37330076 | Mechanisms of cell death in heart disease |
| Q38326656 | Mechanisms of myocardial ischemia-reperfusion injury and the cytoprotective role of minocycline: scope and limitations |
| Q38820532 | Mitochondrial Function, Biology, and Role in Disease: A Scientific Statement From the American Heart Association. |
| Q36582810 | Mitochondrial membrane permeabilization and cell death during myocardial infarction: roles of calcium and reactive oxygen species |
| Q51724014 | Modulation of Fas-Fas Ligand Interaction Rehabilitates Hypoxia-Induced Apoptosis of Mesenchymal Stem Cells in Ischemic Myocardium Niche. |
| Q38244750 | Molecular identity of the mitochondrial permeability transition pore and its role in ischemia-reperfusion injury |
| Q90033657 | Molecular machinery and interplay of apoptosis and autophagy in coronary heart disease |
| Q36430856 | Morphological aspects of apoptosis in heart diseases |
| Q44015655 | Myocyte apoptosis: programming ventricular remodeling. |
| Q40509976 | P38 alpha mitogen-activated protein kinase sensitizes cells to apoptosis induced by different stimuli. |
| Q37189802 | Placental mesenchymal and cord blood stem cell therapy for dilated cardiomyopathy |
| Q33409850 | Potential prognostic significance of decreased serum levels of TRAIL after acute myocardial infarction |
| Q48765555 | Prognostic value of apoptosis markers in advanced heart failure patients. |
| Q37051197 | Programmed cell death in cardiac myocytes: strategies to maximize post-ischemic salvage. |
| Q46230285 | Protein kinase Cdelta activation induces apoptosis in response to cardiac ischemia and reperfusion damage: a mechanism involving BAD and the mitochondria |
| Q37983931 | Redox-mediated programed death of myocardial cells after cardiac arrest and cardiopulmonary resuscitation. |
| Q35063194 | Regulation of cardiac myocyte cell death |
| Q45009519 | Relation of circulating interleukin-6 to left ventricular remodeling in patients with reperfused anterior myocardial infarction. |
| Q45885035 | Retroinfusion of NFkappaB decoy oligonucleotide extends cardioprotection achieved by CD18 inhibition in a preclinical study of myocardial ischemia and retroinfusion in pigs |
| Q37368042 | Role of apoptosis in cardiovascular disease |
| Q37032338 | Simplified apoptotic cascades |
| Q26995349 | Small molecules, big effects: the role of microRNAs in regulation of cardiomyocyte death |
| Q37201502 | Some lessons from the tissue transglutaminase knockout mouse |
| Q39695414 | Suppression of Akt signaling induces Fas ligand expression: involvement of caspase and Jun kinase activation in Akt-mediated Fas ligand regulation |
| Q46801157 | Synchronous progression of calcium transient-dependent beating and sarcomere destruction in apoptotic adult cardiomyocytes |
| Q37997644 | TNF revisited: osteoprotegerin and TNF-related molecules in heart failure |
| Q38194552 | TWEAK-Fn14 Cytokine-Receptor Axis: A New Player of Myocardial Remodeling and Cardiac Failure |
| Q35095412 | Targeting ischemic cardiac dysfunction through gene transfer |
| Q42937750 | Tempero-spatial dissociation between the expression of Fas and apoptosis after coronary occlusion |
| Q44939618 | The Fas receptor-1,4,5-IP3 cascade: a potential target for treating heart failure and arrhythmias. |
| Q36238929 | The Relationship of Serum Soluble Fas Ligand (sFasL) Level with the Extent of Coronary Artery Disease |
| Q37041189 | The effect of high dose melatonin on cardiac ischemia- reperfusion Injury |
| Q40964541 | The role of TNF-α, Fas/Fas ligand system and NT-proBNP in the early detection of asymptomatic left ventricular dysfunction in cancer patients treated with anthracyclines |
| Q34329506 | The role of apoptotic cell death in cardiovascular disease |
| Q40361542 | The tumor necrosis factor superfamily in heart failure |
| Q37774394 | There is more to life than revascularization: therapeutic targeting of myocardial ischemia/reperfusion injury |
| Q37088298 | Toll-like receptor signaling: a critical modulator of cell survival and ischemic injury in the heart |
| Q52724765 | miR‑133b‑5p contributes to hypoxic preconditioning‑mediated cardioprotection by inhibiting the activation of caspase‑8 and caspase-3 in cardiomyocytes. |
Search more.